The article describes our work to develop a liquid biopsy alongside other companies and laboratories in Madison and at the University of...

GenomeWeb.com highlights our new collaboration with BioView for imaging and image analysis.

Seungpyo Hong, PhD, was named the Milton J. Henrichs Chair of Pharmaceutical Sciences in May. A recent article from the University of...

On July 1, Seungpyo Hong, PSD Professor, Director of Wisconsin Center for NanoBioSystems and cofounder of Capio Biosciences, will become...

Professor Seungpyo Hong's work with Capio Biosciences is one of six faculty projects getting a boost from State Economic Engagement and...

Capio Biosciences is pleased to announce receipt of an official Notice of Allowance for U.S. Patent Application Serial No.: 15/123,156 -...

Capio Biosciences is pleased to announce that they have received Qualified New Business Venture (QNBV) certification from WEDC. The QNBV...

Capio Biosciences is pleased to announce receipt of an official Notice of Allowance for patent application # 10-2017-7035887 - "Method...

We are very excited that Andrew Wang MD, Assoc. Prof., Dept. of Radiation Oncology, U. of North Carolina and Cofounder of Capio...

Capio Biosciences is pleased to be recognized by StartUpCity magazine as one of the most promising 15 Biotech startups 2019, and for...

Andrew Z. Wang, MD, CEO, Capio Biosciences will present "Capiocyte: A Highly Sensitive Circulating Tumor Cell Capture Assay for Improving...

Michael Poellmann presented "Quantification and downstream analysis of circulating tumor cells isolated using CapioCyte(TM) liquid...

Capio Biosciences "CapioCyte(TM) technology is featured in this article by John Gilmore of Genome web. https://www.genomeweb.com/cancer/c...

Capio Biosciences, an early stage biotechnology startup company developing a biopsy-free technology for capturing Circulating Tumor Cells...

BUILDING A MOLECULAR DIAGNOSTICS STARTUP FROM THE GROUND UP Download PDF

Two professors at the UW–Madison School of Pharmacy’s Pharmaceutical Sciences Division are up for the challenge of being both...

Seungpyo Hong presented Enhanced Sensitivity of Specificity of Circulating Tumor Cell Capture Using a Synergistic Combination of Cell...

Effective Capture of Circulating Tumor Cells from a Transgenic Mouse Lung Cancer Model using Dendrimer Surfaces Immobilized with...

Seungpyo Hong, founder of the cancer diagnostic company and Madison startup Capio Biosciences, said he met with executives from Foxconn...

Jeff Buchanan | January 5th, 2017 In certain patients who are being treated for cancer, it’s possible for cells to detach from the tumors...